The Latest Breaking News from Vaccine

US firm Moderna is suing its competitors for alleged patent infringement in relation to their Comirnaty vaccine.

On May 11, the central pillar of the country's pandemic response — the declaration of a national emergency that began March 1, 2020 — will come down. But Americans will continue to have access to the vaccines, drugs and medical devices that were authorized for emergency use against COVID-19, so…

Moderna said Wednesday it wouldn’t raise the price of its COVID-19 vaccine after a public outcry.

The U.S. government should face a patent lawsuit over COVID-19 vaccines, not vaccine maker Moderna Inc, the Department of Justice told a Delaware federal court on Tuesday.

An Adelaide Hills woman was overwhelmed with fear and anxiety about the COVID-19 jab before she paid a vulnerable person to take the dose in her name, a court hears.

Public health experts warned from the beginning of the COVID-19 pandemic that the disease was “not like the flu,” resulting in far more deaths and hospitalizations each year.

According to the Centers for Disease Control and Prevention (CDC), routine vaccinations for kindergarten in the U.S. fell to 93% during the 2021-2022 school year. That's the second year in a row routine vaccination rates decreased. The vaccines help prevent potentially fatal or severe illnesses, including diphtheria, measles, mumps, rubella,…

CSL has beaten first-half earnings expectations thanks to its vaccine business and contributions from its new iron deficiency therapy company.

It’s a sharp turn from the Democratic-led panel last year.

Contrary to the widely shared popular belief, the primary purpose of current vaccines against Covid-19 is solely to protect against serious forms of the disease in order to prevent the risk of hospitalisations and death… and not to block transmission between individuals. To do this, it would be necessary to…

Pfizer (PFE) played a pivotal role in developing vaccines and pills that helped the world return to normal from the COVID-19 pandemic. The company reported record revenue and earnings in fiscal 2022. Given the company’s solid growth prospects, it could be wise to invest in the stock right now. Keep…